Novo Nordisk Shares Are Trading Lower Following a Report Suggesting a Study Linked Ozempic to an Increased Risk of a Rare Form of Vision Loss.
Novo Nordisk Shares Are Trading Lower Following a Report Suggesting a Study Linked Ozempic to an Increased Risk of a Rare Form of Vision Loss.
諾和諾德的股票在一份報告公佈後下跌，該報告暗示一項研究將奧澤帕與一種罕見的視力喪失風險增加聯繫起來。
Novo Nordisk Shares Are Trading Lower Following a Report Suggesting a Study Linked Ozempic to an Increased Risk of a Rare Form of Vision Loss.
諾和諾德的股票在一份報告公佈後下跌，該報告暗示一項研究將奧澤帕與一種罕見的視力喪失風險增加聯繫起來。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間